KaloBios terminates Shkreli as CEO
[BENGALURU] Drugmaker KaloBios Pharmaceuticals Inc said it terminated Martin Shkreli as chief executive on Dec 17, the day he was arrested on charges of securities fraud.
Shkreli, who stepped down as CEO of private drugmaker Turing Pharmaceuticals Inc, also resigned from his position on KaloBios' board of directors.
Shkreli was arrested for engaging in what US prosecutors said was a Ponzi-like scheme at his former hedge fund and a pharmaceutical company he previously headed.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue